Hims & Hers raised its full-year 2026 revenue guidance to a range of $2.8 billion to $3 billion, representing growth of 19% to 28% from 2025 levels, and updated adjusted EBITDA guidance to a range of $275 million to $350 million.
Women of childbearing potential should be advised to discontinue semaglutide at least 2 months before a planned pregnancy and to avoid use during pregnancy and lactation
VIVUS LLC reserves the right to modify or discontinue these offers at any time without notice
and, Additional risks to watch out for when taking Ozempic include thyroid C-cell tumors, other thyroid issues, pancreatitis, diabetic retinopathy, acute kidney injury, hypersensitivity, acute gallbladder disease, hypoglycemia (when used with insulin/sulfonylurea), injection site reactions, and allergic reactions
suspectum venom that have received the most attention from researchers are the bioactive peptides, including helodermin, helospectin, exendin-3, and exendin-4